Late effects after an allogeneic transplant (a transplant using donor cells) can affect the physical, psychological, and social well-being of survivors. Dr. Hamilton sheds light on the most common long-term effects and how they can best be managed to minimize complications. She also stresses the importance of ongoing survivorship care to ensure that survivors can live life to the fullest.

Resumen: El trasplante con células de un donante (trasplante alogénico) puede causar efectos tardíos en la salud meses o años después del trasplante. Este video describe posibles complicaciones tardías o a largo plazo después del trasplante, cómo reducir el riesgo de desarrollar complicaciones y opciones de tratamiento.

Long-term health consequences of stem cell transplant using donor cells (an allogeneic transplant) are very real, although they affect a minority of patients and can often be treated effectively. This presentation reviews the most common problems following an allogeneic transplant and the therapies available to treat them.

The number of stem cell transplants performed is increasing, which means more people are concerned about ongoing complications or late effects after transplant. This presentation reviews potential late effects after a stem cell transplant (hematopoietic cell transplant) using donor cells (aka allogeneic transplant).

Great strides have been made in bone marrow, stem cell and cord blood transplantation. An increasing number of patients with blood disorders are now able to enjoy a second chance at life, thanks the efforts of doctors and patients who pioneered this life-saving treatment. This video identifies Nancy McClain, who was transplanted in 1963, as the longest living bone marrow transplant survivor. Since then, we have learned that a six-year-old child named Nancy Lowry was successfully transplanted with bone marrow from her identical twin sister three years earlier in 1960. Nancy Lowry, who went on to be a public health and school nurse, is alive and well today.